Information for Volunteers and Patients

Early phase clinical trials are a vital step in the process of bringing new and safe medicines to the community. Every medicine that is sold over the counter or by prescription has undergone stringent clinical testing to ensure it is safe and effective, and it is this process that is undertaken at Nucleus Network.

The clinical trials performed at Nucleus Network involve either healthy volunteers or patients with specific medical conditions. We rely heavily on community involvement in this process, and are grateful for the time and effort offered by our participants, without whom new medicines would not reach the people who need them most.

Nucleus Network is a not-for-profit clinical research and education company that is wholly owned by the Baker Medical Research Institute. The clinical trials performed at Nucleus Network involve either healthy volunteers or patients with specific medical conditions. The types of medicines that are tested at Nucleus Network are extremely varied but are generally in the early stages of clinical development (phase I). Healthy volunteers are often involved in the earliest research because they are healthy and their bodies are ‘fully fit’ to absorb and process the new medicine. Patients may also be involved in the earliest studies, this is often the case when the new medicine being researched will only have an effect on patients with a specific disease. All clinical trials at NN are carried out according to the National Statement on Ethical Conduct in Human Research (2007) produced by the National Health and Medical Research Council of Australia. Whether you are a healthy volunteer or a patient participating in a clinical research trial, you are playing a part in the advancement of medical knowledge and in bringing new medicines to people who need them.

Click here to download Clinical Research Participant  Information Brochure